Literature DB >> 33758998

Opioids are not a major cause of death of patients with sickle cell disease.

Samir K Ballas1.   

Abstract

According to the Center of Disease Control and Prevention (CDC) database, the total number of deaths due to opioid overdose from 1999 through 2018 was 840,629. Given the alarming nature of these statistics, patients who requested prescription for opioids became targets of suspicion and possible accusation of maladaptive behavior. Patients with sickle cell disease (SCD) were often not exempt from such accusations and became guilty by association. In order to clarify the effect of opioids on the mortality of patients with SCD, the mortality rates for children and adults with SCD were investigated using the CDC Wide-ranging Online Data for Epidemiologic Research (WONDER) Multiple Cause of Death database which is based on all the death certificates issued in the USA from 1999 to 2018. The data showed that 15,765 patients with SCD died from 1999 to 2018. Only 348 patients with SCD died due to opioids. The CDC database contains 27 categories of death based on ICD-10 codes in patients with SCD, and opioids were the 19th ranking cause of death. Surprisingly the most common causes of death of patients with SCD included circulatory, infection, respiratory, genitourinary, and vaso-occlusive crises/acute chest syndrome disorders in decreasing frequency. The mean age of death of females was 41.9 years and of males 39.3 years (p < 0.0001). Death due to SCD and death due to SCD and opioids were highest in the Southern Region of the USA.

Entities:  

Keywords:  Epidemic; Mortality; Opioids; Sickle cell disease

Year:  2021        PMID: 33758998     DOI: 10.1007/s00277-021-04502-2

Source DB:  PubMed          Journal:  Ann Hematol        ISSN: 0939-5555            Impact factor:   3.673


  2 in total

1.  Drug seeking or pain crisis? Responsible prescribing of opioids in the emergency department.

Authors:  Pamela L Pentin
Journal:  Virtual Mentor       Date:  2013-05-01

2.  Mortality in children, adolescents and adults with sickle cell anemia in Rio de Janeiro, Brazil.

Authors:  Clarisse Lopes de Castro Lobo; Emilia Matos do Nascimento; Leonardo José Carvalho de Jesus; Thiago Gotelip de Freitas; Jocemir Ronaldo Lugon; Samir K Ballas
Journal:  Rev Bras Hematol Hemoter       Date:  2017-12-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.